Summary
Torrent Pharmaceuticals reported a robust 3% rise in profit after tax to Rs 566 crore for the first quarter, with revenue soaring to Rs 4,921 crore. The company saw significant growth across various regions, including a 19% increase in Indian revenue and a 36% increase in US revenue.